FDA Approval Can't Nix Allergan Patent Obviousness: Sandoz
Generic-drug maker Sandoz Inc. urged a Federal Circuit panel on Monday to lift an injunction banning it from marketing a generic version of Allergan Inc.'s glaucoma medication Combigan, saying the lower...To view the full article, register now.
Already a subscriber? Click here to view full article